RecruitingNCT06938100

Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL


Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

100 participants

Start Date

Nov 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The project aims to retrospectively and prospectively analyze a population of CADASIL patients in order to study the natural history of the disease by correlating the symptom spectrum with genetic risk and specific neuroradiological and biological markers \- Stratifying patients according to their disease risk, this could contribute to the discovery of personalized therapeutic targets.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cadasil (diagnosis) and cadasil. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Hospital Universitario de la Princesa, Madrid

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06938100


Related Trials